[Studies of protein clearance in patients treated with and without gold preparations in rheumatoid arthritis].
It is reported on investigations of protein clearance in rheumatics treated with Tauredon in comparison to non-treated patients suffering from rheumatoid arthritis. In that way no significant differences concerning the secretion of selective and unselective proteins could be found between the observed groups of patients. Secondary effects of the gold therapy in the form of a relevant proteinuria as elaborated by some authors cannot be confirmed in our patients. On the other hand investigations of protein clearance allow the premature recognition of renal failure and thus they can contribute to the increasing of the patients' security in the application of this therapy.
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001798:Blood Proteins / Q000378:metabolism; D006052:Gold Sodium Thiomalate / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D011507:Proteinuria / Q000139:chemically induced*
D001798:Blood Proteins; D006052:Gold Sodium Thiomalate
Proteinclearanceuntersuchungen bei mit und ohne Goldpräparaten behandelten Patienten mit Rheumatoid-Arthritis.